Literature DB >> 26339382

Downregulation of growth differentiation factor-15 in trichostatin A-induced apoptosis could play a role in progression of gastric cancer.

Yun-Long Li1, Wu Cui1, Feng Gao1, Zhi-Gang Cao1, Xiao-Lin Li1, Wen-Xue Zhou1.   

Abstract

AIM: To investigate the effect of trichostatin A (TSA) on gastric cancer cell line BGC-823, and identify the differentially expressed genes induced by TSA, which might participate in the progression of gastric cancer.
METHODS: MTT, fluorescence microscopy, and flow cytometry were used to detect the effect of TSA on growth inhibition and apoptosis of BGC-823 cells. Using gene microarray, we analyzed the changes in gene expression. Change in growth differentiation factor-15 (GDF-15) was verified by qRT-PCR and Western blotting. The expression of GDF-15 in gastric cancer and adjacent normal tissues was detected by immunohistochemistry.
RESULTS: Apoptosis of BGC-823 cells induced by TSA (75 ng/mL for 48 h) was demonstrated by flow cytometry. There were significant variations between TSA treated groups and control groups (P = 0.02). Nuclear chromatin condensation and fluorescence intensity were observed by fluorescence microscopy. GDF-15 gene expression and protein level were significantly reduced in the TSA treated group (75 ng/mL for 48 h). Immunohistochemistry demonstrated that the expression of GDF-15 in gastric adenocarcinoma was significantly higher than in the surrounding normal tissues (P < 0.05).
CONCLUSION: Lower GDF-15 gene expression due to TSA-induced apoptosis was found in gastric cancer cell line BGC-823. Higher GDF-15 gene expression was seen in gastric adenocarcinoma tissues.

Entities:  

Keywords:  BGC-823; Gastric cancer; apoptosis; growth differentiation factor-15; trichostatin A

Mesh:

Substances:

Year:  2015        PMID: 26339382      PMCID: PMC4555710     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  GDF-15: a novel serum marker for metastases in uveal melanoma patients.

Authors:  Daniela Suesskind; Andreas Schatz; Sven Schnichels; Sarah E Coupland; Sarah L Lake; Bernd Wissinger; Karl U Bartz-Schmidt; Sigrid Henke-Fahle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

2.  Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma.

Authors:  Lei Zhang; Xiao Yang; Hong-ya Pan; Xiao-jian Zhou; Jiang Li; Wan-tao Chen; Lai-ping Zhong; Zhi-yuan Zhang
Journal:  Oral Oncol       Date:  2008-09-19       Impact factor: 5.337

3.  Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells.

Authors:  Jayashree P Joshi; Nicole E Brown; Samantha E Griner; Rita Nahta
Journal:  Biochem Pharmacol       Date:  2011-07-23       Impact factor: 5.858

4.  High Twist expression is involved in infiltrative endometrial cancer and affects patient survival.

Authors:  Satoru Kyo; Junko Sakaguchi; Satoshi Ohno; Yasunari Mizumoto; Yoshiko Maida; Manabu Hashimoto; Mitsuhiro Nakamura; Masahiro Takakura; Miki Nakajima; Kenkichi Masutomi; Masaki Inoue
Journal:  Hum Pathol       Date:  2006-04       Impact factor: 3.466

5.  Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.

Authors:  Seung Joon Baek; Jong-Sik Kim; Scott M Moore; Seong-Ho Lee; Jeanelle Martinez; Thomas E Eling
Journal:  Mol Pharmacol       Date:  2004-10-27       Impact factor: 4.436

6.  Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.

Authors:  Krishan K Rasiah; James G Kench; Margaret Gardiner-Garden; Andrew V Biankin; David Golovsky; Phillip C Brenner; Raji Kooner; Gordon F O'neill; Jennifer J Turner; Warick Delprado; C Soon Lee; David A Brown; Samuel N Breit; John J Grygiel; Lisa G Horvath; Phillip D Stricker; Robert L Sutherland; Susan M Henshall
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-04       Impact factor: 4.254

7.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

8.  MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma.

Authors:  David A Brown; Robyn L Ward; Philip Buckhaults; Tao Liu; Katharine E Romans; Nicholas J Hawkins; Asne R Bauskin; Kenneth W Kinzler; Bert Vogelstein; Samuel N Breit
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

9.  Gastric cancer cell lines induced by trichostatin A.

Authors:  Xiao-Ming Zou; Yun-Long Li; Hao Wang; Wu Cui; Xiao-Lin Li; Song-Bin Fu; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

10.  Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer.

Authors:  Sukhwinder Kaur; Subhankar Chakraborty; Michael J Baine; Kavita Mallya; Lynette M Smith; Aaron Sasson; Randall Brand; Sushovan Guha; Maneesh Jain; Uwe Wittel; Shailender K Singh; Surinder K Batra
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

View more
  1 in total

1.  Expression of the Body-Weight Signaling Players: GDF15, GFRAL and RET and their clinical relevance in Gastric Cancer.

Authors:  Karolina Buchholz; Paulina Antosik; Dariusz Grzanka; Maciej Gagat; Marta Smolińska; Alina Grzanka; Arkadiusz Gzil; Anna Kasperska; Anna Klimaszewska-Wiśniewska
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.